NCT01234064

Brief Summary

This is a pilot substudy to the PeriOperative ISchemic Evaluation-2 Trial (POISE-2), to assess the feasibility of adding graduated compression stockings (GCS) to POISE-2 as an intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2010

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

November 2, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 4, 2010

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

January 18, 2012

Status Verified

December 1, 2011

Enrollment Period

1.1 years

First QC Date

November 2, 2010

Last Update Submit

January 16, 2012

Conditions

Keywords

Symptomatic Venous ThromboembolismGraduated Compression StockingsRandomized Controlled TrialNoncardiac Surgery

Outcome Measures

Primary Outcomes (1)

  • Objectively confirmed symptomatic major venous thromboembolism

    The primary outcome to assess efficacy will be a comparison of the proportion of patients who have objectively confirmed symptomatic major venous thromboembolism (defined as proximal deep vein thrombosis or pulmonary embolism) within 30 days of randomization (includes episodes that are diagnosed in response to symptoms reported at the 30 day assessment).

    30 days

Secondary Outcomes (3)

  • Any symptomatic venous thromboembolism or pulmonary embolism

    30 days

  • Major venous thromboembolism and death

    30 Days

  • Safety Outcomes

    30 Days

Study Arms (2)

Graduated Compression Stockings

ACTIVE COMPARATOR
Device: Anti-Embolism Graduated Pressure Stockings (by BSN-Jobst)

No Graduated Compression Stockings

OTHER
Device: No Graduated Compression Stockings

Interventions

Apply 2 to 4 hours prior to surgery. Patient will continue to wear stockings until post-op Day 10.

Also known as: Anti-Em/GP
Graduated Compression Stockings

No stockings will be applied.

No Graduated Compression Stockings

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Randomized to PeriOperative ISchemic Evaluation-2 Trial (POISE-2 Trial)

You may not qualify if:

  • Unable to wear a graduated compression stockings on a leg that has been operated on (e.g., below knee skin grafting)
  • Leg has not been operated on and graduated compression stockings cannot be worn on either leg (e.g. bilateral leg amputations or skin ulceration, allergy to material in the graduated compression stockings)
  • Graduated compression stockings cannot be fitted because the patient's legs are too big, or too small (not compatible with manufacturer's recommendations)
  • The responsible physician/nurse judges that graduated compression stockings are contraindicated because of: i) decreased circulation in the legs as evidenced by very pale, cyanotic, or gangrenous conditions; or ii) risk of stocking-induced skin necrosis due to an established sensory neuropathy with numbness to touch.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henderson Hospital

Hamilton, Ontario, Canada

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Clive Kearon, MB, PhD

    McMaster University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 2, 2010

First Posted

November 4, 2010

Study Start

November 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

January 18, 2012

Record last verified: 2011-12

Locations